[
  {
    "ts": null,
    "headline": "CVS makes deal with Glenview Capital, adds four board seats",
    "summary": "Glenview CEO Larry Robbins will join the CVS board effective immediately",
    "url": "https://finnhub.io/api/news?id=869d5d264802301e79c1c5bb1e66861f6d0f32f96f7413f386ff3740d8cad422",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732045642,
      "headline": "CVS makes deal with Glenview Capital, adds four board seats",
      "id": 131491863,
      "image": "https://eu-images.contentstack.com/v3/assets/blt58a1f8f560a1ab0e/blta1141e9ce0b1ef0d/673cebd11e14c371e8e123ec/A_CVS_storefront.png?disable=upscale&width=1200&height=630&fit=crop",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Glenview CEO Larry Robbins will join the CVS board effective immediately",
      "url": "https://finnhub.io/api/news?id=869d5d264802301e79c1c5bb1e66861f6d0f32f96f7413f386ff3740d8cad422"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "CVS Health Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a991f61e677354dc783d3a20739a9ac45e888755e8c036bc88f4d0eaeb1990eb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732034880,
      "headline": "CVS Health Corp. stock underperforms Tuesday when compared to competitors",
      "id": 131512209,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a991f61e677354dc783d3a20739a9ac45e888755e8c036bc88f4d0eaeb1990eb"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health names Dr. Sreekanth Chaguturu President, Health Care Delivery",
    "summary": "CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company.",
    "url": "https://finnhub.io/api/news?id=3b40180d57214967da02abc3e2b43a0e73aa8efcf2de1cd860c13f2b2ba8d6e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732030200,
      "headline": "CVS Health names Dr. Sreekanth Chaguturu President, Health Care Delivery",
      "id": 131491864,
      "image": "https://media.zenfs.com/en/prnewswire.com/a36c51c34c468155e15f8fa0a51f2cb8",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company.",
      "url": "https://finnhub.io/api/news?id=3b40180d57214967da02abc3e2b43a0e73aa8efcf2de1cd860c13f2b2ba8d6e0"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)",
    "summary": "CVS Health Corporation (NYSE:CVS) Wolfe 2024 Healthcare Results Conference November 19, 2024 10:20 AM ETCompany ParticipantsTom Cowhey - Executive Vice...",
    "url": "https://finnhub.io/api/news?id=8a57ccbee124cac77fd8b93a9a0e15b3d416190d20d62f71273459b0331ab94a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732021262,
      "headline": "CVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)",
      "id": 131480182,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "CVS Health Corporation (NYSE:CVS) Wolfe 2024 Healthcare Results Conference November 19, 2024 10:20 AM ETCompany ParticipantsTom Cowhey - Executive Vice...",
      "url": "https://finnhub.io/api/news?id=8a57ccbee124cac77fd8b93a9a0e15b3d416190d20d62f71273459b0331ab94a"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Impact Mortgage Fund Q3 2024 Commentary",
    "summary": "3Q24(notannualized)YTD(notannualized)1 Year3 Year5 Years10 YearsInstitutional5.614.5312.15-1.710.031.29Investor A (Without Sales...",
    "url": "https://finnhub.io/api/news?id=f5be13ee3262ff7f7a4b85b9c2f70d4528e073d9b95024b3df35e57f69c79aec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732019040,
      "headline": "BlackRock Impact Mortgage Fund Q3 2024 Commentary",
      "id": 131478108,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1462296278/image_1462296278.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "3Q24(notannualized)YTD(notannualized)1 Year3 Year5 Years10 YearsInstitutional5.614.5312.15-1.710.031.29Investor A (Without Sales...",
      "url": "https://finnhub.io/api/news?id=f5be13ee3262ff7f7a4b85b9c2f70d4528e073d9b95024b3df35e57f69c79aec"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock High Equity Income Fund Q3 2024 Commentary",
    "summary": "BlackRock High Equity Income Fund posted returns of 6.71% (Institutional shares) and 6.63% (Investor A shares, without sales charge) for the third quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=c1865b375fb14494cb05b4ae5c2a78cbeb14dc47addcc7d407a32562ba6c4148",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732017900,
      "headline": "BlackRock High Equity Income Fund Q3 2024 Commentary",
      "id": 131477085,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1421629295/image_1421629295.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "BlackRock High Equity Income Fund posted returns of 6.71% (Institutional shares) and 6.63% (Investor A shares, without sales charge) for the third quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=c1865b375fb14494cb05b4ae5c2a78cbeb14dc47addcc7d407a32562ba6c4148"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Upgrades CVS Health (CVS)",
    "summary": "Wells Fargo Upgrades CVS Health (CVS)",
    "url": "https://finnhub.io/api/news?id=da206b608ef0304fabb3b6f7ba0d4729f55f57858323115894b3917e216741df",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732016782,
      "headline": "Wells Fargo Upgrades CVS Health (CVS)",
      "id": 131469441,
      "image": "",
      "related": "CVS",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=da206b608ef0304fabb3b6f7ba0d4729f55f57858323115894b3917e216741df"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo upgrades CVS Health to Overweight, ups price target to $66",
    "summary": "As previously reported, Wells Fargo upgraded CVS Health (CVS) to Overweight from Equal Weight with a price target of $66, up from $60. The firm believes the negative consequences of aggressive growth strategies at Aetna have likely peaked and creates a compelling investment opportunity. Medicare Advantage and Exchange improvement should happen through pricing/benefit changes and Medicaid should happen with rate cycle, Wells says. Its base case represents a 25% annualized stock return and 30% tot",
    "url": "https://finnhub.io/api/news?id=c95cbdfe4fb738cee814b5e1a18f9232cda69b7bfba01a85c098e684634fa662",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732014976,
      "headline": "Wells Fargo upgrades CVS Health to Overweight, ups price target to $66",
      "id": 131491865,
      "image": "",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As previously reported, Wells Fargo upgraded CVS Health (CVS) to Overweight from Equal Weight with a price target of $66, up from $60. The firm believes the negative consequences of aggressive growth strategies at Aetna have likely peaked and creates a compelling investment opportunity. Medicare Advantage and Exchange improvement should happen through pricing/benefit changes and Medicaid should happen with rate cycle, Wells says. Its base case represents a 25% annualized stock return and 30% tot",
      "url": "https://finnhub.io/api/news?id=c95cbdfe4fb738cee814b5e1a18f9232cda69b7bfba01a85c098e684634fa662"
    }
  },
  {
    "ts": null,
    "headline": "Company News for Nov 19, 2024",
    "summary": "Companies In The News Are: TWST, CVS, OKLO, HSIC.",
    "url": "https://finnhub.io/api/news?id=c429245e76fb63957ce2e2c81cf7fc85ce803e40fa3d29a5aa2100e9c84606c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732012920,
      "headline": "Company News for Nov 19, 2024",
      "id": 131470857,
      "image": "https://media.zenfs.com/en/zacks.com/9436dc85af727f654580c502748fd7c3",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Companies In The News Are: TWST, CVS, OKLO, HSIC.",
      "url": "https://finnhub.io/api/news?id=c429245e76fb63957ce2e2c81cf7fc85ce803e40fa3d29a5aa2100e9c84606c8"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Mid-Cap Value Fund Q3 2024 Commentary",
    "summary": "BlackRock Mid-Cap Value Fund posted returns of 7.87% (Institutional shares) and 7.83% (Investor A shares, without sales charge) for the third quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=d0cf8466260f7b1f5e984a09b5079071b0638d3fd675e3048c0e40b87fade8b8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732002180,
      "headline": "BlackRock Mid-Cap Value Fund Q3 2024 Commentary",
      "id": 131469617,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "BlackRock Mid-Cap Value Fund posted returns of 7.87% (Institutional shares) and 7.83% (Investor A shares, without sales charge) for the third quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=d0cf8466260f7b1f5e984a09b5079071b0638d3fd675e3048c0e40b87fade8b8"
    }
  }
]